What's hot

View all perspectives
What's Hot

Daily Recap - WEDNESDAY

Join panelists Drs. Janet Pope, Richard Conway, Meral El Ramahi and Jack Cush recap the best presentations presented on day four of the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

EXXELERATE Study: Do High RF Titers Impact Response to TNF Inhibitors?

Dr. Jonathan Kay discusses abstract 2148 with Dr. Josef Smolen at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

Bimekizumab in Active AS: 5 Year Study

Dr. Atul Deodhar reporting on abstract 0519 from the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

Cannabinoid Receptor in RA Patients

Dr. Arthur Kavanaugh discusses abstract 0025 at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

Treatments in SpA

Dr. Rachel Tate and Dr. Catherine Blakewell discuss treatment options patients in spondyloarthritis at the 2023 ACR Convergence meeting in San Diego, CA. Abstracts discussed include 0520, 0530, 0521 and 0529.

Watch video →

PR3+ in Lupus Nephritis

Dr. Jack Cush discusses abstract 2427 presented at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

Simulated Trials to Counter ORAL Survelliance

Dr. Jack Cush and Dr. Janet Pope at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

Difficult to Treat axSpA

Dr. Peter Nash reports on abstracts 0514 and 0538 from the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

Window of Opportunity in PsA

Dr. Peter Nash discusses a study that looks at the window of opportunity for treatment of PsA at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

TMP SMX Prophylaxis in GPA

Dr. Jack Cush and Dr. Janet Pope discuss abstract 1584 presented at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

The FOREMOST Study: Apremilast in PsA

Dr. Peter Nash reports on abstract 1691 presented at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

The SMART Study: Split Dose Oral Methotrexate

Dr. Jack Cush discusses abstract 1583 presented at the 2023 ACR Convergence meeting in San Diego.

Watch video →

Real World Experience with PEXIVAS Low Steroid Taper

Dr. Mike Putman discusses abstract 0725 with Dr. Sophie Nagle at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →
38420215_s.jpg

Cancer and TNF inhibitors

Cancer risk minimisation is a high priority for people with rheumatic diseases, as it is for the general population. Tumor necrosis factor inhibitors (TNFi) have a long history of association with cancer risk discussions. An oral presentation by Suarez-Almazor et al provided more supportive data on using TNFi in this population.

Read more →
ACR Best

#ACRbest Abstracts – Day 2

Our reporters have been prolific in finding the hot abstracts, those that were most attended or those that are getting the most buzz on social media.  Here are RheumNow's #ACRbest abstract reports from Monday, November 13, 2023 at #ACR23, covering The Great Debate, SGLPT2 inhibitors in SLE, the SMART Study of MTX, TMP/SMX Prophylaxis, RA-ILD & TNF Inhibitors, cancer research and more. 

Read more →

Effects of Apremilast on Cardiometabolic Effects in PsA

Dr. Peter Nash discusses abstract 1414 at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →

An Interview with Kevin Winthrop: Three Questions About COVID 19

Drs. Jack Cush and Kevin Winthrop discuss COVID 19 at 2023 ACR Convergence in San Diego, CA.

Watch video →

Biologics as First-line Therapy for PMR and GCA?

Dr. Eric Dein talks with Dr. Philip Seo, one of two panelists for the Great Debate: Should PMR and GCA Be Treated with Advanced Therapies at Disease Onset? at the 2023 ACR Convergence meeting in San Diego, CA.

Watch video →
      Assessment of organ involvement in scleroderma by Boin F, a great example of great clearly presented slides #ACR23 @Rheu

      Dr. Antoni Chan

      2 years ago
      Assessment of organ involvement in scleroderma by Boin F, a great example of great clearly presented slides #ACR23 @RheumNow https://t.co/zMwY1NGpYI
      Need to point out limitations of QSTs too! Need trained researchers. Need some sort of quantification to help.
      Mechanis

      Bella Mehta bella_mehta

      2 years ago
      Need to point out limitations of QSTs too! Need trained researchers. Need some sort of quantification to help. Mechanism specific pain management is the goal! @RheumNow #ACR23 https://t.co/Frcger9ZUk
      RheumNow’s expanded coverage of the #ACR23 annual meeting is sponsored in part by Novartis. All content is chosen by

      Dr. John Cush RheumNow

      2 years ago
      RheumNow’s expanded coverage of the #ACR23 annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty.
      The message about scleroderma we need to keep on saying to those outside of rheumatology:

      you can get severe organ invo

      David Liew drdavidliew

      2 years ago
      The message about scleroderma we need to keep on saying to those outside of rheumatology: you can get severe organ involvement in both limited & diffuse SSc survival is dictated by organ involvement screening is needed regardless! Francesco Boin #ACR23 Review Course @RheumNow https://t.co/otUPjWNVoo
      Women are more sensitive to pain!
      Disconnect between the clinical problem and rat studies which are predominantly male!

      Bella Mehta bella_mehta

      2 years ago
      Women are more sensitive to pain! Disconnect between the clinical problem and rat studies which are predominantly male! Sex as a biological variable! Policies change behavior! Now data is more balanced! @rheumnow #ACR23 https://t.co/NluYR25TtM
      Chronic pain affects mortality!! Men with more pain sites (which correlates with numerical pain too) had higher early mo

      Bella Mehta bella_mehta

      2 years ago
      Chronic pain affects mortality!! Men with more pain sites (which correlates with numerical pain too) had higher early mortality compared to women- study in a large UK sample. @rheumnow #ACR23
      Some key facts on Axial Spondyloarthritis, the overall ratio of M:F is 1:1, so not a male predominant condition #AxSpa O

      Dr. Antoni Chan

      2 years ago
      Some key facts on Axial Spondyloarthritis, the overall ratio of M:F is 1:1, so not a male predominant condition #AxSpa Ogdie A #ACR23 @RheumNow https://t.co/mfp9YIIdue
      This is the real challenge of nr-axSpA: knowing where people land, and who will radiographically progress.

      Alexis Ogdie

      David Liew drdavidliew

      2 years ago
      This is the real challenge of nr-axSpA: knowing where people land, and who will radiographically progress. Alexis Ogdie #ACR23 Review Course @RheumNow https://t.co/r4y6nwfvhG
      ACR Convergence Preview

      https://t.co/DGSIl7sK3r https://t.co/vH5vnkh8tV

      Dr. John Cush RheumNow

      2 years ago
      ACR Convergence Preview https://t.co/DGSIl7sK3r https://t.co/vH5vnkh8tV
      Microbiome in #OA - is it hype or real? @CurlyGeneticist talks about the triad of gut microbiome, OA and obesity. @Rheum

      Bella Mehta bella_mehta

      2 years ago
      Microbiome in #OA - is it hype or real? @CurlyGeneticist talks about the triad of gut microbiome, OA and obesity. @RheumNow #ACR23 -Streptococcus spp. -Increased pain independent of obesity tho! -Blood gut barrier is broken? https://t.co/uSVSWXDLfy
      Mic drop moments in #OA research by David Walsh! Focus on the bone- subchondral bone main be the PAIN POINT. @rheumnow #

      Bella Mehta bella_mehta

      2 years ago
      Mic drop moments in #OA research by David Walsh! Focus on the bone- subchondral bone main be the PAIN POINT. @rheumnow #ACR23 https://t.co/PxCQ68YsTx
      Type III relapsing polychondritis has the MAGIC and VEXAS groups, with genital ulcers and haematological manifestations,

      Dr. Antoni Chan

      2 years ago
      Type III relapsing polychondritis has the MAGIC and VEXAS groups, with genital ulcers and haematological manifestations, 8% of RP patients have VEXAS, Ferrada M, #ACR23 @RheumNow https://t.co/FsmBK0F7ZD
      Pain without inflammation might be a myth! We need to understand a lot of immune cells before saying that! Important pe

      Bella Mehta bella_mehta

      2 years ago
      Pain without inflammation might be a myth! We need to understand a lot of immune cells before saying that! Important perpheral drivers may be important to study too! #ACR23 @RheumNow https://t.co/VaRC1WAmiJ
      On way to #ACR23 via Denver. good news - got upgraded, bad news late flight so tight connection. Looking forward to scie

      Janet Pope

      2 years ago
      On way to #ACR23 via Denver. good news - got upgraded, bad news late flight so tight connection. Looking forward to science, meeting in person and perfect weather….and did I say shopping, zoo, parks and food! @rheumnow https://t.co/611Y2QnfjR
      What’s not to love 💗 about #San Diego #ACR23 convention center? @ACRheum Follow reports @RheumNow for great updates

      Janet Pope

      2 years ago
      What’s not to love 💗 about #San Diego #ACR23 convention center? @ACRheum Follow reports @RheumNow for great updates! https://t.co/6CrQ4ifnzt

      Podcasts

      • Rheumatology Roundup
      • JAK - TYK2 Topic Panel
      • JAK - TYK2 Topic Panel

      Catch up on Conference Podcasts

      ×